Capricor Therapeutics (4LN2.F) Q2 2026 Earnings

May 12Confirmed
Q2 2025
Q3 2025
Q4 2025
Q2 2026
-0.5
-0.43
-0.36
-0.28

Details

Expected EPS
-0.44546893543000005
Actual EPS
-0.5026741
Surprise EPS
-0.06
Surprise Percent
-12.84%

Description

⁨Capricor Therapeutics⁩ (⁦4LN2.F⁩) has reported earnings of ⁦-0.5026741⁩ per share for ⁦Q2 2026⁩.

0 Comments

Share your thoughts